ClinicalTrials.gg
RecruitingNCT05162560Updated Mar 7, 2024

Incidence and Outcome of Acute Diverticulitis in Finland

An observational study in Acute Diverticulitis, sponsored by Kuopio University Hospital. Recruiting at 1 site in Finland. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-03-07.

Sponsored by Kuopio University Hospital · Observational

From the registry’s dates

  • Started Jan 2009; still recruiting 17 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
15,000
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The incidence of acute diverticulitis (AD), conservative vs. surgical treatment and outcome of patients are studied using national registries and patient charts from two hospitals between years 2009-19.

Read the detailed description

Acute diverticulitis (AD) of colon is increasing in Finland. Incidence, prevalence and mortality of AD of colon are investigated during 10-year period (2009-2019) in whole country. Epidemiological data is compared to data of acute appendicitis. Nationwide data of patients with AD are asked from Finnish Institute for Health and Welfare (THL). To compare registry-based nationwide data, patient charts from electronic database of two hospitals (Mikkeli Central Hospital and Tampere University Hospital) are reviewed from same study period. Patient characteristics, medication, treatment (conservative vs surgery), recurrence of AD and long-term outcome are recorded.

02

Conditions studied

  • Acute Diverticulitis

Browse trials for

03

In context

Diverticulitis

125 studies on the registry are indexed under Diverticulitis; 22 are open to participants now.

This study's planned enrollment of 15,000 is above the median of 275 across 59 observational studies indexed under Diverticulitis.

Browse Diverticulitis studies →

Lead sponsor

Kuopio University Hospital is the lead sponsor of 135 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

patients with acute diverticulitis is whole Finland and in two study hospitals during years 2009-2019

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all patients with acute diverticulitis (K57) in Finland and in two hospitals

Exclusion criteria

Exclusion Criteria:

  • other reasons for acute or chronic abdominal pain
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
15,000 participants (estimated)
Patient registry
No

Interventions

  • Otherpatients with acute diverticulitis

    registry and hospital charts of patients with acute diverticulitis

06

What researchers measure

Primary outcomes

  1. Rate of annual incidence and prevalence of acute diverticulitis

    how many patients with acute diverticulitis are treated in all hospitals in Finland

    Time frame: January 2009-December 2019

Secondary outcomes

  1. Number of patients with surgical or conservative treatment

    Number of patients with conservative or surgical treatment of acute diverticulitis in two hospitals

    Time frame: January 2009-December 2019

  2. Number of treatment complications and survival of patients with acute diverticulitis

    outcome of patients with acute diverticulitis in two hospitals

    Time frame: January 2009-December 2019

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05162560
Collaborators
Tampere University Hospital, Mikkeli Central Hospital
Responsible party
Sponsor
First posted
Dec 17, 2021
Start date
Jan 1, 2009
Primary completion
Dec 1, 2021
Completion
Dec 31, 2024 (estimated)
Last update
Mar 7, 2024

Study contacts

Hannu EK Paajanen, MD
Contact
paajanen@surffi.fi
+358405263101
Tuomo Rantanen, MD
Contact
tuomo.rantanen@kuh.fi
+358504028461
Hannu EK Paajanen, MD
principal investigator · Eastern Univerisity of Finland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion